Hospital Conference on Hallucinogenic Drug.—
The first invitational conference of Napa State Hospital, Imola, a symposium on lysergic acid diethylamide (LSD-25), will be presented for staff and guests on Saturday, Jan. 16, sponsored jointly by the hospital and Sandoz Pharmaceuticals. Basic science aspects of this hallucinogenic drug will be discussed during the morning, and the afternoon session will encompass the clinical and therapeutic status of the drug. Dr. Sidney V. Cohen, chairman, research committee, Veterans Administration Center, Neuropsychiatric Hospital, Los Angeles, will be the guest lecturer. Other participants will include faculty members from Stanford and the University of California Medical School, Langley Porter Neuropsychiatric Institute, and practicing Psychiatrists and psychologists.
British Epidemiologist Named Public Health Chairman.—
Dr. Anthony Monck-Mason-Great Britain, w is now chief medical officer forofficer for enemo-epidemic h Organization in Geneva, will become Anna M. R. Lauder Professor of Public Health and chairman of a reorganized